Oracle
ORCL
Toll Brothers
TOL
Vale SA
VALE
4
Apple
AAPL
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
SPRY ARS Pharmaceuticals
- 14.115
- +0.345+2.51%
Trading Apr 28 15:42 ET
1.38BMarket Cap176.44P/E (TTM)
14.270High13.845Low750.13KVolume13.890Open13.770Pre Close10.52MTurnover1.61%Turnover Ratio176.44P/E (Static)98.12MShares18.51052wk High5.39P/B656.64MFloat Cap7.55052wk Low--Dividend TTM46.52MShs Float63.410Historical High--Div YieldTTM3.09%Amplitude2.550Historical Low14.029Avg Price1Lot Size
About ARS Pharmaceuticals Company
ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.
Company Profile
SymbolSPRY
Company NameARS Pharmaceuticals
Listing DateDec 4, 2020
Founded2015
CEOMr. Richard E. Lowenthal, M.B.A.,M.S.
MarketNASDAQ
Employees160
Fiscal Year Ends12-31
Address11682 El Camino Real,Suite 120
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-206-456-2900
Websitehttp://www.ars-pharma.com
Company Executives
- Name
- Position
- Salary
- Richard E. Lowenthal, M.B.A.,M.S.
- President, Chief Executive Officer and Director
- 10.04M
- Kathleen D. Scott
- Chief Financial Officer and Principal Accounting Officer
- --
- Justin Chakma
- Chief Business Officer
- --
- Eric Karas
- Chief Commercial Officer
- --
- Brian T. Dorsey
- Chief Operating Officer
- --
- Alexander A. Fitzpatrick
- Chief Legal Officer and Secretary
- 5.32M
- Dr. Sarina Tanimoto, M.B.A.,M.D.
- Chief Medical Officer
- --
- Dr. Pratik Shah, PhD
- Chairman of the Board
- 508.80K
- Brenton L. Saunders
- Director
- 238.80K
- Dr. Laura Shawver, PhD
- Director
- 238.80K
- Saqib Islam, J.D.
- Independent Director
- 250.05K
- Phillip M. Schneider
- Independent Director
- 261.30K
- Michael Kelly
- Independent Director
- 248.80K
- Dr. Rajeev Dadoo, PhD
- Independent Director
- 256.30K
- Dr. Peter Kolchinsky, PhD
- Independent Director
- 253.80K
- Dr. Peter A. Thompson,M.D.,F.A.C.P.
- Independent Director
- 242.55K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call